News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current PKPH market cap is 121.46M. The company's latest EPS is USD -0.0021 and P/E is -738.10.
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -28k | -6k | -6k | -69k | -163k |
| Net Income | -28k | -14k | -15k | -76k | -165k |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2k | 1,000 | 0 | 261k | 130k |
| Total Liabilities | 223k | 236k | 250k | 587k | 621k |
| Total Equity | -221k | -235k | -250k | -326k | -491k |
| Year End September 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -44k | -1,000 | -1,000 | -14k | -68k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 43k | N/A | N/A | 275k | -65k |
| Market Cap | 121.46M |
| Price to Earnings Ratio | -738.10 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 968.75 |
| Price to Book Ratio | -247.38 |
| Dividend Yield | - |
| Shares Outstanding | 78.36M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -77.86% |
| 52 Week High | 9.12 |
| 52 Week Low | 1.37 |
| Spread (Intraday) | 1.03 (39.77%) |
| Company Name | Peak Pharmaceuticals Inc (PK) |
| Address |
14201 n. hayden road, suite a-1, scottsdale, az 85260 |
| Website | https://www.peakpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
